Aberrant overexpression of IKKα protein is associated with decreased patient survival and promotes the growth of lung adenocarcinoma; it may therefore be used as a biomarker to predict clinical response in lung adenocarcinoma patients19. The gene discussed is CHUK; the disease is lung adenocarcinoma.